Afghanistan

According to 2013 UNAIDS HIV/AIDS estimates, approximately 4500 Afghans are living with HIV with highest prevalence (4.4%) among injection drug users (IDUs). Despite low national HIV prevalence, Afghanistan has been identified as high risk for an HIV epidemic. According to a 2013 World bank article, HIV/AIDs In Afghanistan, "The HIV epidemic is concentrated mainly among injecting drug users. Afghanistan’s emerging epidemic likely hinges on a combination of injecting drug use and unsafe paid sex." The Afghanistan Ministry of Public Health has developed a strategic framework to maintain low HIV prevalence, which has inlcuded the establishment of the Afghanistan National AIDS Control Program (NACP) in 2003.

CCGHE RESPONDS

CCGHE has partnered with the Afghanistan NACP to develop and implement an eMOCHA®-based mobile Health application to optimize HIV prevention efforts.

CCGHE-AFGHANISTAN ACTIVITIES

Megan Buresh, MD

Baltimore, Maryland
Kathleen Page was a research adviser in 2010 for Ms. Buresh, who is now Clinical Associate, Johns Hopkins Bayview Medical Hospital. Outcome: Abstract (first author) at XIX International AIDS Conference (AIDS 2012) 22-27 July, 2012 in Washington D.C. 1 peer-reviewed publication (co-first author)
Subscribe to RSS - Afghanistan